BillionLive Creator Incentive Program & Long-Term Leaderboards The World Cup may be over, but streaming, creating, trading, and predicting continue. After The Goal Rush season, BillionLive’s three leaderboards will remain as long-term platform features. The Creator Leaderboard is now a weekly ranking, with steady rewards for creators. Creator Weekly Leaderboard Open to non-contracted BillionLive creators. Going live, posting updates and short videos, attaching prediction cards, inviting new users, building communities, and sharing BillionLive content on X all count toward your weekly contribution score. The weekly Top 10 will share 666 USDT + 10,750 Billion Points. The leaderboard resets every Monday at 00:00, with rewards distributed each Tuesday. Trader Leaderboard & Prediction P&L Leaderboard Open to all users. The Trader Leaderboard tracks historical cumulative trading volume, while the Prediction P&L Leaderboard tracks cumulative net profit from settled prediction orders. Neither leaderboard resets or carries fixed rewards. Long-term performance may be considered for future events, tier benefits, and exclusive perks. All three leaderboards go live on July 27. A new week, a new leaderboard. Leave your name on it. Event page: Watch, predict and win big on #Billionlive# BillionLive 创作者激励计划与长期排行榜上线 世界杯会结束，但开播、创作、交易和预测不会停。 The Goal Rush 赛季结束后，BillionLive 三榜将作为平台长期功能保留。其中，创作者榜升级为每周榜，继续为认真做内容的人提供一份稳定的奖励。 创作者周榜 面向 BillionLive 非签约创作者开放。开播、发布动态和短视频、挂载预测卡片、邀请新用户、经营社区、在 X 分享内容，都将计入本周综合贡献分。 每周 Top 10 将共同瓜分 666 USDT + 10,750 Billion Points。榜单每周一 00:00 重置，奖励于每周二发放。 交易者榜与预测盈利榜 面向全体用户开放。交易者榜记录历史累计交易量，预测盈利榜记录已结算订单的累计净盈利；两榜均不重置，也不设置固定奖励。后续的活动资格、等级权益和专属福利，将优先参考长期表现。 三榜将于 7 月 27 日正式开启。新的一周，新的榜单，留下你的名字。 活动链接： 看直播，玩预测，就来 #Billionlive#

$PGR（Progressive） 5.8.1 快照与技术选股归属：现价222.88，市值129.58B，52周区间189.2到239.38，现金及等价物138.0M，短期投资10005.0M，流动性合计10143.0M，季度经营现金流3607.0M为正，跑道不适用（经营现金流为正，不依赖现金消耗），年度财报12/31/2025收入87671.0M，净利润11308.0M，研发无M，资本支出-348.0M，季度财报6/30/2026收入23609.0M，净利润3311.0M，流动比率nan%，毛利率17.18%，营业利润率16.54%（数据来源：个股基本面快照，2026-10-14）；技术选股D组硬条件命中，分数58.55，获利盘93.15%，套牢盘6.85%，90%集中度6.92（数据来源：技术选股，2026-10-14）。 5.8.2 主营业务与产品技术亮点：Progressive是美国车险龙头，主营个人汽车保险、房屋保险与商业保险。核心技术亮点包括直接分销与代理人双渠道，基于驾驶行为的UBI定价技术，理赔数字化与快速结算能力。本条不写数字。 5.8.3 事件促发点：2026-10-14 Progressive发布财报，预期EPS为4.46，涉及季度业绩，量级判断重大，方向待定（数据来源：未来5日财报日历，2026-10-14）。暂无其他已公开促发点。 5.8.4 大行研报与消息汇总：目标价均值无，买入无，持有无，卖出无（数据来源：Nasdaq分析师库，2026-10-14）。Barclays目标价246上调至247，上调0.4%，头部国际大行，距现价16.4%（数据来源：MarketBeat 2026-10-07）；HSBC目标价221下调至216，下调-2.3%，非头部，距现价1.79%（数据来源：MarketBeat 2026-10-07）。消息面：Zacks对PGR发出混合展望（Foreign Policy Journal 2026-10-13）。 5.8.5 关键价位、触发与失效：日线支撑筹码峰206.04距现价8.17%，日线压力20日高223.78距现价0.4%，周线支撑周线MA10为216.7距现价2.77%，周线压力52周高239.38距现价7.4%（数据来源：个股筹码四元组与关键价位，2026-10-14）。触发条件为放量突破20日高223.78，失效条件为跌破筹码峰206.04。资金共振同向项数2项（数据来源：3.1节，2026-10-14）。 5.8.6 情景：牛档239.38（周线压力52周高），基准档223.78（日线压力20日高），熊档206.04（日线支撑筹码峰）。从现价到周线压力空间7.4%。 5.8.7 结论：等触发，1到2周期望幅度至223.78约0.4%，赔率中性，建议观察，最大风险是财报不及预期。第一目标223.78，第二目标239.38。 5.9 $BIIB（Biogen） 5.9.1 快照与技术选股归属：现价228.9，市值33.82B，52周区间138.0到238.24，现金及等价物3008.5M，短期投资807.2M，流动性合计3815.7M，季度经营现金流448.9M为正，跑道不适用（经营现金流为正，不依赖现金消耗），年度财报12/31/2025收入9890.6M，净利润1292.9M，研发1778.6M，资本支出-153.8M，季度财报6/30/2026收入2736.0M，净利润97.5M，流动比率267.9%，毛利率75.69%，营业利润率18.83%（数据来源：个股基本面快照，2026-10-14）；技术选股D组硬条件命中，分数38.68，获利盘97.73%，套牢盘2.27%，90%集中度11.81（数据来源：技术选股，2026-10-14）。 5.9.2 主营业务与产品技术亮点：Biogen是生物技术公司，主营多发性硬化、阿尔茨海默病与神经科学药物。核心技术亮点包括神经科学管线深度，阿尔茨海默病抗体药物，与Eisai等合作伙伴的全球商业化能力。本条不写数字。 5.9.3 事件促发点：2026-10-12 JPMorgan升级至Overweight，目标价210上调至300，涉及评级与目标价，量级判断重大，方向利多（数据来源：MarketBeat 2026-10-12）。暂无其他已公开促发点。 5.9.4 大行研报与消息汇总：目标价均值241.96，区间175.0到300.0，买入17家，持有6家，卖出1家，下期EPS预测12.41（Dec 2026），近4周EPS上修2家下修1家（数据来源：Nasdaq分析师库，2026-10-14）。JPMorgan升级至Overweight，目标价210上调至300，上调42.9%，头部五大，距现价32.91%（数据来源：MarketBeat 2026-10-12）；UBS目标价240上调至270，上调12.5%，头部国际大行，距现价21.7%（数据来源：MarketBeat 2026-10-09）；BMO目标价未披露至220，来源弱，非头部，距现价-5.12%（数据来源：MarketBeat 2026-10-12）。消息面：无。 5.9.5 关键价位、触发与失效：日线支撑筹码峰217.12距现价5.43%，日线压力20日高238.24距现价4.08%，周线支撑周线MA10为221.97距现价3.03%，周线压力52周高238.24距现价4.08%（数据来源：个股筹码四元组与关键价位，2026-10-14）。触发条件为放量突破20日高238.24，失效条件为跌破筹码峰217.12。资金共振同向项数3项（数据来源：3.1节，2026-10-14）。 5.9.6 情景：牛档238.24（周线压力52周高，与日线压力同位），基准档217.12（日线支撑筹码峰），熊档221.97（周线支撑周线MA10）。从现价到周线压力空间4.08%。 5.9.7 结论：可买，1到2周期望幅度至238.24约4.1%，赔率中性偏多，建议半仓，最大风险是神经科学药物竞争加剧。第一目标238.24，第二目标无更高参照，突破后重算。

Who, in their wildest delusion, is trying to weaponize 'overcapacity' — while the 'China Dividend' is actually powering the world? 谁在妄言“产能过剩”？“中国红利”正在驱动全球！ Recently, the phrase "China's overcapacity" has been appearing with striking frequency. In North America and Europe, it comes up in think tank reports, trade hearing testimonies, and political speeches — all in remarkably uniform tone. But interestingly, the louder the outcry, the more the actual market moves in the opposite direction. This summer, European consumers rushed to buy Chinese air conditioners — in the first half of this year, China's air conditioner exports to the EU surged 43.2% year-on-year, hitting a record high. Meanwhile, developers worldwide are flocking to Chinese large-language models — on OpenRouter, a multi-model aggregation platform, all top-five models by weekly calls come from Chinese companies. One vote is cast with wallets; the other, with code. If there really were "overcapacity," why would the market still be scrambling for these products? The so-called "China overcapacity" is, in the final analysis, a false proposition that cannot withstand market scrutiny. Recently, China's Ministry of Commerce released a 12,000-word position paper titled "The So-Called 'Overcapacity' Issue: China's Position," which gets to the root of the "overcapacity" narrative. The document systematically responds to relevant international discussions and firmly pushes back against the erroneous argument that "Chinese subsidies cause overcapacity." One sentence in the paper cuts straight to the heart: "A large export volume and a trade surplus of a country are the inevitable outcome of the international division of labor in the era of economic globalization." The weight of this statement becomes particularly clear when viewed against the broader coordinates of global economic development. In psychology, there is a concept called "attribution theory": people tend to make "internal attributions" for their successes — crediting their own efforts — but lean toward "external attributions" when facing problems, shifting blame to outside factors. This tendency is especially pronounced among trade protectionists. When their industries fail to keep pace with the times, fall behind, or suffer from domestic hollowing-out, they point fingers outward and blame China. When 80% of U.S. chips are exported and two-thirds of Boeing aircraft are sold overseas, that is touted as industrial strength. When the EU runs hundreds of billions of dollars in trade surpluses year after year in automobiles, pharmaceuticals, and cosmetics, that is called normal international trade. Yet when China exports a lot, why is that suddenly "overcapacity"? Why is that "dumping at low prices"? Different yardsticks yield different conclusions — this is double standards in action. What is more telling is that by now, the "overcapacity" hype has long ceased to be a purely economic issue; it has been fully reduced to a tool of geopolitical rivalry in the West. The U.S. enacted the Inflation Reduction Act, doubling down on exclusionary local protectionism; the EU introduced the Industrial Accelerator Act, directly tying subsidies to local production. They pay lip service to fair competition, but in reality, they are erecting targeted trade barriers — a classic case of saying one thing and doing another. No matter whether the trade protectionists in North America and Europe are genuinely misguided or willfully obtuse, China's attitude remains clear and steadfast: we openly embrace healthy global market competition, but we will never allow normal commercial rivalry to be deliberately escalated and twisted into geopolitical confrontation. If we cut through the fog of rhetoric and take an honest look at the reality of international trade, we will see that the sustained growth of China's exports is rooted in the genuine global demand for green transition and industrial upgrading. Take the new energy sector as an example: Chinese photovoltaic modules now hold over 90% of the global market share, and Chinese power batteries account for more than 70% of global shipments. This is not ineffective excess capacity piling up in the domestic market; rather, it is the large-scale industrial advantages of China precisely matching the urgent global need for green transformation. More importantly, the global demand for new energy is far from peaking. The International Energy Agency projects that from 2025 to 2030, global installed renewable energy capacity will double, with nearly 80% of that growth coming from solar photovoltaic. By 2030, annual global sales of new energy vehicles are expected to reach ten times the 2023 level. Therefore, China's industrial expansion overseas has never been a "market shock" — it is a development dividend that benefits the entire world. The numbers speak for themselves: over the past decade and more, China's contribution to global economic growth has remained steady at around 30%. China has been the world's second-largest importer for 17 consecutive years and is a major export destination for nearly 80 countries. It has implemented zero-tariff treatment for 63 countries and is the world's first major economy to offer zero-tariff coverage for all African countries that have diplomatic relations with it, as well as for all least-developed countries that have diplomatic ties with it. China is the only country in the world that hosts an International Import Expo, which has been successfully held for eight sessions, with cumulative intended transaction volume exceeding $580 billion. During the 14th Five-Year Plan period, China's cumulative imports surpassed $90 trillion. The trade surplus may stay in China, but the industrial dividends, jobs, and development opportunities have genuinely benefited the entire world. Trade barriers may block Chinese products, but they cannot stop the advance of technological progress, the momentum of industrial rise, or the market's choice as expressed through its own votes: China is not only an increasingly robust "world factory" but also a vibrant "world market." China's modern industrial development is not "China Shock 2.0" for the world — it is "China Opportunity 2.0." 最近，"中国产能过剩"这六个字，出现的频率有点高。在北美与欧洲，智库提，贸易听证会提，政客演讲也提，调子出奇地一致。但有意思的是，嘴上喊得越凶，真实的市场，越是朝着相反的方向走。 今年夏天，欧洲的消费者争相抢购中国空调 —— 上半年中国对欧盟空调出口额同比暴涨 43.2%，创下历史新高。全球的开发者追捧中国的大模型 —— 多模型聚合平台 OpenRouter 的周度调用量榜单上，排名前五的产品全部来自中国企业。一个用钱包投票，一个用代码投票。 如果真的"过剩"，市场为什么还在抢？所谓"中国产能过剩"，说到底，是个经不住市场检验的伪命题。 最近，中国商务部发布了一份1.2万字的立场文件——《关于所谓"产能过剩"问题的中方立场》，一口气把“产能过剩论”的根给刨了。这份文件系统回应了国际上的相关讨论，正面回击了"中国补贴造成产能过剩"的错误论调。 文件里有一句话，直击要害："一个国家出口规模大、存在贸易顺差，是经济全球化下国际产业分工造就的必然结果。"这句话的分量，放在全球经济发展的坐标系里看，会格外清楚。心理学有个“归因理论”：人们看待成绩时喜欢“内部归因”，认为是自己努力的结果；面对问题时则倾向“外部归因”，把矛盾归咎于外部因素。在贸易保护主义者身上，这种现象尤其明显。一些国家的产业发展跟不上时代了，落伍被淘汰了，或者是国内产业空心化了，就把锅往外甩，说是中国的问题。 美国芯片80%用于出口，波音飞机三分之二销往海外被称作产业优势；欧盟汽车、医药、化妆品常年保持数百亿贸易顺差被叫做正常国际贸易。同样是出口多，到了中国这里，怎么就成了"产能过剩"？怎么就成了"低价倾销"？标准不同，结论当然不同，这就是双重标准。 更值得深思的是，炒到现在，"产能过剩"早就不单纯是一个经济问题了，它已经彻底沦为西方地缘博弈的工具。美国出台《通胀削减法案》，大搞本土排他性保护；欧盟推出《工业加速器法案》，把补贴和本地生产直接绑定。嘴上标榜的是公平竞争，实际构筑的却是针对性的贸易壁垒，典型的“说一套，做一套”。 不管北美与欧洲的贸易保护主义者是真糊涂还是装糊涂，中国的态度始终清晰而坚定：我们坦然接受全球良性市场竞争，但绝不允许正常的商业竞争被刻意升级、扭曲成地缘政治对抗。 拨开舆论的迷雾，正视国际贸易的现实就会发现，中国出口的持续增长，根源在于全球绿色转型和产业升级的真实刚需。以新能源产业为例，中国光伏组件全球市场占有率超过 90%，动力电池全球出货量突破 70%。这不是国内市场积压的无效过剩，而是中国产业的规模化优势，精准匹配了全球绿色转型的迫切需求。更关键的是，全球新能源市场的需求，远远没有触顶。国际能源署预测，2025年到2030年，全球可再生能源装机总量将翻一番，其中近80%的增量来自太阳能光伏；到2030年，全球新能源汽车的年销量，将达到2023年的十倍。所以，中国产业出海从来不是什么 "市场冲击"，而是普惠全球的发展红利。 数据就摆在那里：过去十多年，中国对世界经济增长的贡献率常年稳定在30%左右。中国进口规模连续17年居全球第二，是近80个国家的主要出口目的地；对63个国家实施零关税，是全球首个对所有非洲建交国和所有建交的最不发达国家实现全覆盖零关税的主要经济体；中国是全球唯一举办国际进口博览会的国家，已成功举办8届，累计意向成交额超5800亿美元；“十四五”时期累计进口规模超90万亿元…… 贸易顺差留在中国，但产业红利、就业岗位、发展机遇，实实在在惠及了全世界。贸易壁垒，可以挡住中国的产品，却挡不住技术进步的脚步，挡不住产业崛起的大势，更挡不住市场用脚投票的选择：中国不仅是日益强大的“世界工厂”，更是活力旺盛的“世界市场”。中国现代化产业发展对世界不是“中国冲击2.0”，而是“中国机遇2.0”。 #China# #Jiangxi# #世界经济看中国# #赣出新精彩#